FAIR Labels Act of 2026

Overview

• Bill: S.4464 (Fair and Accurate Ingredient Representation on Labels Act of 2026), 119th Congress, 2nd Session
• Introduced by: Senator Rickett(s) (for himself and Senator Fetterman)
• Purpose: Amend the Federal Meat Inspection Act, the Poultry Products Inspection Act, and related law provisions to ensure consumers can clearly distinguish meat and poultry products from cell-cultivated protein products and plant-based alternatives on labels and in standards.

Main purpose and intent

• Establish clear labeling and regulatory parity to help consumers make informed choices among traditional meat/poultry products, cell-cultivated protein products, and plant-based alternatives.
• Require explicit labeling terms and disclosures for products that are cell-cultivated or plant-based, preventing confusion with conventional animal-derived products.

Key provisions and changes

1) Regulatory framework and interagency alignment

• Revisions to a Memorandum of Understanding between USDA (Secretary of Agriculture) and HHS/FDA to clarify regulatory responsibilities for cell-cultivated protein products.
  • Within 90 days of enactment, the agencies must jointly update the MOU to:
  • Define roles for USDA in implementing act amendments.
  • Have FDA oversee premarket consultations on production materials, cell banks, manufacturing controls, tissue collection, and inputs.
  • Assign responsibilities for cell collection, cell banks, proliferation/differentiation, and compliance with FDA-related requirements (facility registration, good manufacturing practices, preventive controls, etc.).
  • Establish inspection and enforcement mechanisms for cell banks and culturing facilities.

2) Regulation and labeling of cell-cultivated protein products

• Adds explicit definitions:
  • Cell-cultivated protein product: a product used as human food derived from animal cell culture technology and grown outside the live animal.
• Misbranding and labeling requirements for cell-cultivated proteins (Meat Inspection Act) include:
  • Prominent labeling of “cell-cultivated” next to the product name.
  • A statement that the product is derived from sources other than meat.
  • A disclaimer that the final product is not derived from, or does not contain, naturally produced meat from a live animal.
• Applicability extension:
  • Cell-cultivated products are regulated under the same framework as meat products (for the Meat Inspection Act), with similar enforcement provisions.

3) Regulation and labeling of cell-cultivated poultry products

• Adds similar definitions and misbranding protections for cell-cultivated poultry:
  • Requires labeling with “cell-cultivated,” a statement that the product is derived from sources other than poultry, and a disclaimer about not containing meat from a live bird.
• Applicability extension to Poultry Products Inspection Act (PPIA), ensuring cell-cultivated poultry products are regulated similarly to conventional poultry.

4) Plant-based alternative proteins

• Adds a new definition in the Food, Drug, and Cosmetic Act:
  • Plant-based alternative protein product: a plant-derived product that mimics meat/powltry in texture, flavor, and appearance and is manufactured to appear as a meat product.
• Labeling requirements for plant-based products:
  • Must label as “plant-based alternative protein product.”
  • Must disclose that the product is not derived from, or does not contain, naturally produced meat or poultry.
• Ensures visibility and clarity for consumers differentiating plant-based products from animal-derived products.

5) Standards of identity

• Requires development of common standards of identity within 180 days of enactment:
  • For cell-cultivated protein products and plant-based alternatives.
  • Standards aligned with the definitions in the Federal Meat Inspection Act, PPIA, and the Federal Food, Drug, and Cosmetic Act.

Who and what would be affected

• Cell-cultivated protein manufacturers (both meat- and poultry-derived cell-cultured products) would face explicit labeling and regulatory requirements.
• Plant-based protein manufacturers would be subject to new labeling standards to distinguish their products.
• Regulators: USDA and FDA/HHS would share oversight roles, with updated coordination through the revised MOU and new enforcement responsibilities.
• Consumers: Gains clearer labeling to distinguish traditional meat/poultry from cell-cultivated and plant-based products, aiding informed purchasing decisions.

Procedural and timeline aspects

• Effective date is not specified in the excerpt, but key timelines include:
  • Within 90 days post-enactment: Joint revision of the MOU between USDA and FDA.
  • Within 180 days post-enactment: Secretary of Agriculture, in consultation with HHS, to develop common standards of identity for cell-cultivated and plant-based products.
• The bill would apply labeling and regulatory requirements to cell-cultivated products and plant-based products consistent with the amended acts.

Summary

S.4464 seeks to create a standardized, transparent labeling regime and regulatory framework to differentiate traditional meat and poultry products from cell-cultivated protein and plant-based alternatives. It strengthens misbranding provisions, expands interagency oversight, and develops common product standards to ensure consumers can readily identify the nature and source of protein products on the market.